Krystyna Jedrychowicz‐Rosiak
- Immunology top 5%
- Pediatrics, Perinatology and Child Health top 5%
- Rheumatology top 5%
- Economics and Econometrics top 5%
- Epidemiology
- Co-authors
- Eva DokoupilováAsta BaranauskaitėAgnieszka ZielińskaJaroslaw NiebrzydowskiMichael E. WeinblattMargarita PileckytėArtur RacewiczJanusz Jaworski
- Topics
- Biosimilars and Bioanalytical Methods (9 papers)Pharmaceutical studies and practices (7 papers)Rheumatoid Arthritis Research and Therapies (6 papers)
- Partner nations
- South KoreaLithuaniaCzechia
In The Last Decade
Krystyna Jedrychowicz‐Rosiak
10 papers receiving 523 citations
Peers
Comparison fields: 5 of 35
- Immunology 464
- Pediatrics, Perinatology and Child Health 210
- Rheumatology 190
- Economics and Econometrics 180
- Epidemiology 76
Countries citing papers authored by Krystyna Jedrychowicz‐Rosiak
This map shows the geographic impact of Krystyna Jedrychowicz‐Rosiak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krystyna Jedrychowicz‐Rosiak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krystyna Jedrychowicz‐Rosiak more than expected).
Fields of papers citing papers by Krystyna Jedrychowicz‐Rosiak
This network shows the impact of papers produced by Krystyna Jedrychowicz‐Rosiak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krystyna Jedrychowicz‐Rosiak. The network helps show where Krystyna Jedrychowicz‐Rosiak may publish in the future.
Co-authorship network of co-authors of Krystyna Jedrychowicz‐Rosiak
This figure shows the co-authorship network connecting the top 25 collaborators of Krystyna Jedrychowicz‐Rosiak. A scholar is included among the top collaborators of Krystyna Jedrychowicz‐Rosiak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krystyna Jedrychowicz‐Rosiak. Krystyna Jedrychowicz‐Rosiak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 101 | |
| 2 | 98 | |
| 3 | 44 | |
| 4 | 110 | |
| 5 | 7 | |
| 6 | 8 | |
| 7 | Sustained Efficacy and Comparable Safety and Immunogenicity after Transition to SB5 (an Adalimumab Biosimilar) Vs. Continuation of SB5 or Reference Adalimumab (Humira®) in Patients with Rheumatoid Arthritis: Results of Phase III Study | 3 |
| 8 | 138 | |
| 9 | 7 | |
| 10 | 9 |
About Krystyna Jedrychowicz‐Rosiak
Krystyna Jedrychowicz‐Rosiak is a scholar working on Immunology, Rheumatology and Pediatrics, Perinatology and Child Health, having authored 10 papers that have together received 525 indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (9 papers), Pharmaceutical studies and practices (7 papers) and Rheumatoid Arthritis Research and Therapies (6 papers). The work is most often cited by research in Immunology (464 citations), Rheumatology (190 citations) and Pediatrics, Perinatology and Child Health (210 citations). Krystyna Jedrychowicz‐Rosiak has collaborated with scholars based in South Korea, Lithuania and Czechia. Frequent co-authors include Eva Dokoupilová, Asta Baranauskaitė, Agnieszka Zielińska, Jaroslaw Niebrzydowski, Michael E. Weinblatt, Margarita Pileckytė, Artur Racewicz, Janusz Jaworski, Jeehoon Ghil and Mevludin Mekić. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Arthritis & Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.